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ies]. ConClusions: PCPDs contribute to improving QOL for patients at the EoL and 
reduce the time they spend in the ICU. This systematic review is part of a mega-
analysis (a multi-intervention appraisal) about EoL care, and its recommendations 
will inform policies regarding the delivering quality EoL care for Ontarians.
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RelationSHiP Between Medicaid eligiBility and tiMe to Re-
incaRceRation of PReviouSly incaRceRated SuBjectS witH 
ScHizoPHRenia
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objeCtives: Many persons with schizophrenia qualify for Medicaid coverage, thus 
prompt re-acquisition of Medicaid eligibility following release from incarceration 
should lower the risk of re-incarceration. The objective of this study was to assess 
the effect of Medicaid eligibility on risk of re-incarceration among schizophrenia 
diagnosed subjects. Methods: Study subjects were selected between 1/1/2006 and 
9/30/2011 from a Medicaid database merged with department of corrections data 
for a single state. Subjects were adults (18-62 years) with diagnosed schizophrenia 
(ICD 9-CM= 295.xx). Covariates included age, race, gender, marital status, and rea-
son for incarceration. Time to Medicaid eligibility post-release, cumulative days of 
eligibility, and eligibility on re-incarceration date were evaluated in two independ-
ent Cox regression models (1 and 3-year followup) evaluating the hazard for re-
incarceration. Results: A total of 932 subjects were included: 26.5% white, 73.7% 
male, 73.5% single/divorced, 12.7% incarcerated for a substance abuse violation, 
average age 37.6 years. Over the one-year follow-up period, 110 subjects (11.8%) were 
re-incarcerated while over three year follow-up, 209 (22.4%) were re-incarcerated. 
Age (in years) was the only significant predictor of re-incarceration for the one 
year model (HR = 0.976, 95% CI 0.957, 0.994). Eligibility was a significant predictor 
in the three-year follow-up model. A longer ‘time to first eligibility’ (HR = 1.046, 95% 
CI= 1.017, 1.075) was associated with a greater hazard for re-incarceration. Being 
Medicaid eligible at the time of re-incarceration (HR= 0.659, 95% CI = 0.498, 0.870), the 
cumulative number of months of eligibility (HR= 0.978, 95% CI= 0.958, 0.997) and age 
were associated with a lower hazard for re-incarceration (HR= 0.986, 95% CI= 0.973, 
0.999). ConClusions: Among schizophrenia diagnosed subjects, Medicaid eligibil-
ity at release and older age were associated with a lower risk of re-incarceration. 
Access to Medicaid and associated health services post-release may be a factor in 
helping to reduce re-incarceration risk.
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objeCtives: Three draft measures have been proposed by the Pharmacy Quality 
Alliance’s Medication Safe Use Workgroup to examine the quality of opioid use 
related to the dose of the medications over time, access to the medications and 
the combination of both of these criteria. The purpose of this study was to conduct 
a sensitivity analysis so as to identify the appropriate thresholds that should be 
utilized in the numerator of these preliminary measures. Methods: Medicaid fee-
for-service beneficiaries aged ≥ 18 years, with continuous 12 month enrollment, 
and two or more prescription claims for opioids that total ≥ 15 days supply on at 
least two separate days during 2012 were identified in the Mississippi Medicaid 
administrative claims data. Representative opioids comprised of those included 
in the ‘CDC Injury Center Morphine Milligram Equivalent (MME) Table.’ Morphine 
Equivalent Dose (MED) was calculated using the following formula: (Submitted 
Quantity*Strength*MME Conversion Factor)/Days Supply. Unique prescribers and 
pharmacies were identified by their national provider identifier number. Results: 
The sample (10,297 beneficiaries) was predominantly female (73.0%), Caucasian 
(52.2%), and had an average age of 44.33 years. 2.6% (6.3%) and 1.9% (5.3%) of the 
beneficiaries received prescriptions for opioids > 100mg MED and > 120mg MED 
respectively, for ≥ 90 consecutive (non-consecutive) days. 21.9% (5.9%) of the benefi-
ciaries received prescriptions for opioids from ≥ 4 prescribers OR (AND) ≥ 4 pharma-
cies. 0.34% (0.11%) and 1.25% (0.42%) beneficiaries received prescriptions for opioids 
> 120mg MED for ≥ 90 consecutive and nonconsecutive days respectively, and from 
≥ 4 prescribers OR (AND) ≥ 4 pharmacies. ConClusions: The sensitivity analysis 
revealed data for critical decision points for the PQA Workgroup. Health plans that 
are considering the adoption of similar measures, in order to plan their respective 
interventions, will benefit from seeing the breakdown.
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objeCtives: We examined the association between depression and Ambulatory 
Care Sensitive Hospitalizations (ACSH) among Medicare beneficiaries. Methods: 
We adopted a retrospective cross-sectional design using merged survey and fee-for-
service Medicare claims data from 2002-2009 Medicare Current Beneficiary Survey. 
Our study sample consisted of community-dwelling fee-for-service Medicare enroll-
ees with any of the following chronic conditions: arthritis, cancer, diabetes, heart 
disease, hypertension, respiratory diseases, and osteoporosis. ACSH and depression 
were identified using ICD-9-CM Codes. The dependent variables were: any “chronic 
ACSH” (diabetes short-term complications, diabetes long-term complications, 
chronic obstructive pulmonary disease (COPD), hypertension, congestive heart fail-
ure (CHF), angina without a procedure, uncontrolled diabetes, adult asthma and/or 
lower extremity amputations) and “acute ACSH” (dehydration, bacterial pneumonia 
and/or urinary infections), and “any ACSH”. We separately examined ACSH for CHF, 
objeCtives: Determine the factors influencing mammography prescription dur-
ing physician office visits in the U.S and to also determine whether primary care 
physicians or gynecological practitioners have a higher likelihood of prescribing 
mammograms. The study will also examine the possible change in the likelihood 
of mammography prescription over time for different age groups during 2008-2010 
as a result of the 2009 USPSTF screening recommendations. Methods: This cross-
sectional study uses data from National Ambulatory Medical Care Survey. The study 
sample consists of female patients > 40 years, who had a physician office visit in 
the US during 2008-2010. Women with current diagnosis of breast cancer were 
excluded from the study. Logistic regressions were used for the analysis. Results: 
Women visiting a physician for preventive care were approximately eight times 
more likely to be prescribed a mammogram (OR:7.916, 95%CI:4.697-13.340). Women 
residing in non-metropolitan statistical areas were less likely to be prescribed a 
mammogram (OR:0.461, 95%CI:0.238-0.893). Mammography prescription by physi-
cians did not vary by race-ethnicity, insurance coverage, region of residence and 
time spent with the physician. As compared to primary care physicians, obstetrics 
and gynecologist were two times more likely to prescribe a mammogram (OR:2.713 
95%CI:1.395-5.277). In the year 2008 and 2010, there were no statistically significant 
differences in mammography prescriptions across age groups. However in 2009, 
women aged 50-54 (OR:2.053 95%CI:1.061-3.975), 55-59 (OR:2.085 95%CI:1.063-4.089), 
60-64 (OR:2.037 95%CI:1.100-3.775) and 70-74 (OR:2.511 95%CI:1.047-6.026) were two 
times more likely to get a mammography prescription as compared to 40-49 year 
old women. ConClusions: Physician specialty, nature of visit and residence in 
metropolitan statistical areas are important determinants of receiving a mammog-
raphy prescription. In the year 2009 there was a fall in mammography prescription 
for 40-49 year old women as compared to older age groups, however this drop did 
not persist in 2010.
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objeCtives: The aim of this study was to evaluate the impact of missed clinic 
appointments on the time in therapeutic international normalized ratio range (TTR) 
in an inner-city underserved minority population. Methods: A cross-sectional 
survey and cohort study were conducted in patients treated with warfarin and 
managed at the University of Illinois at Chicago Antithrombosis Clinic. Patient 
social, demographic, and clinical characteristics were compared using paramet-
ric and non-parametric tests as appropriate and weighted linear regression using 
propensity scores was performed to identify the association between patients with 
≥ 15% missed clinic appointments and TTR. Results: A total of 291 consecutive 
patients responded to the survey and were included in the study. Patients with ≥ 
15% missed clinic appointments had lower mean age (51.36 ± 17.62 vs. 57.18 ± 16.97, 
p = 0.0051), lower TTR (44.97 ± 19.63 vs. 53.25 ± 20.36 p = 0.0007), a higher number of 
total clinic appointments for monitoring (21.25 ± 8.37 vs. 16.28 ± 7.73, p = < 0.0001), 
higher non-adherence with warfarin therapy (16.10 ± 14.02 vs. 10.22 ± 12.85, p = 
< 0.0001) and longer duration of therapy (4.38 ± 5.91 years vs. 2.71 ± 3.26 years, p = 
0.0009) compared to patients with < 15% missed clinic appointments. Based on the 
results of the unadjusted bivariate regression model, patients with ≥ 15% missed 
clinic appointments had significantly lower TTR (β = -8.43, 95% CI: -13.10, -3.76, p 
= 0.0004). After adjusting for confounders using inverse probability weights, the 
association between missed clinic appointments and TTR remained significant (β = 
-6.30, 95% CI: -11.18, -1.42, p = 0.0115). ConClusions: Missed clinic appointments 
for anticoagulation management negatively affected the quality of anticoagula-
tion control. Future studies should evaluate factors associated with missed clinic 
appointments and the feasibility of more accessible high-quality models of care in 
underserved minorities.
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objeCtives: This evidence-based analysis (EBA) is a systematic review of the effec-
tiveness of patient care planning discussions (PCPDs) between patients/ families 
and providers in improving patient-centred outcomes for people nearing the end 
of life (EoL). Methods: A literature search was performed using MEDLINE, Embase, 
CINAHL, and EBM Reviews for studies published from January 1, 2004 to October 9, 
2013. Included studies must be in English, include adults at the EoL, utilize selected 
study designs [i.e. randomized controlled trials (RCTs), observational studies, sys-
tematic reviews, meta-analyses], and focus on discussion-based interventions for 
planning EoL care. Titles and abstracts were reviewed by a single reviewer and full-
text articles were obtained when appropriate. Reference lists were examined for 
additional relevant studies. The quality of the evidence was evaluated using GRADE. 
When appropriate, meta-analyses were performed. Results: The search yielded 
5,316 citations, and 13 RCTs and 17 observational studies were selected for inclusion 
in the quantitative evidence synthesis, which is still underway. Preliminary results 
showed that, compared to no PCPDs, PCPDs involving providers from at least one 
discipline led to increases in quality of life (QOL). Interventions that included tools 
to facilitate PCPDs (e.g. question list) did not perform better than their controls (2 
studies showing mean differences of 0.01, p> 0.05 and 0.10, p> 0.05). Having PCPDs 
earlier in the illness course was associated with higher QOL (adjβ = 0.003, p= 0.006; 
1 study). PCPDs with a multidisciplinary team of providers led to fewer days in 
the intensive care unit (ICU) [pooled estimate: -6.68 (95% CI: -10.71, -2.65); 2 stud-
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pound this public health problem, general practitioners (GPs) may play a major role 
to fill this treatment gap. Methods: A cross-sectional survey of 220 GPs was under-
taken in Chandigarh City, India. The 20-item Depression Attitude Questionnaire 
(DAQ) was used to determine their knowledge, attitude and practice towards depres-
sion and its management in primary care settings. Results: GPs had a limited 
knowledge of depression, with the majority (77.8%) expressing difficulty working 
with depressed patients. They exhibited moderately stigmatizing attitudes towards 
individuals with depression. GPs were conservative in their use of antidepressants 
and believed that psychotherapeutic approaches were useful. ConClusions: 
These findings suggest a need for further education of general practitioners on the 
nature, diagnosis and management of depressive disorders.
PHS160
develoPing a PoPulation-BaSed Palliative and end-of-life caRe 
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objeCtives: To develop a population-based decision-analytic model to sup-
port decision-making with end-of-life care policy questions. Methods: Design: 
Microsimulation state-transition model with one-day cycle. Population: Patients and 
their family Outcomes: Dying at home, resources used, costs, and quality-adjusted 
survival. Perspectives: Societal and health system. Time horizon: last year of life and 
1-year bereavement. Costs: health system, out-of-pocket, and costs of time loss 
from paid-work. Effects: health-related quality of life (HRQOL, including valuation 
of leisure time) and quality-adjusted life days. Model structure – Stratified by end-of-
life trajectory (below) and risk of dying, simulated individuals might receive cura-
tive, palliative or hospice care (including combined care) at home (including “home 
care”), long-term care homes, ERs, hospitals (including ICU), complex-continuing-
care facilities, palliative care wards, or non-home hospices. Input data sources –a 
cohort study using linked Ontario health administrative databases and literature 
for HRQOL estimates associated with trajectory (e.g., cancer) and interventions 
(e.g. reduced hospital and ICU days). Model validation –Modeled projections were 
calibrated to observed data to ensure consistency. Results: The study cohort strati-
fied 256,284 Ontarians who died between Jan-2007 and Dec-2009 into: sudden death 
(4%), frailty (30%), terminal illnesses (31%), and organ failure (31%). Over the time 
horizon, approximately 60% of the simulated patients were at home with primary/
community/home care support, and 75% spent ≥ 1 day in hospitals, costing the 
health system on average approximately $31,000 (or in aggregation, approximately 
6% of the annual health care budget). Simulated patients died at home (22%), long-
term-care homes (18%), in ERs (6%), hospitals (47%), and complex-continuing-care 
facilities (7%). ConClusions: Upon further validation, our model can be used to 
evaluate the cost-effectiveness of broad integrated palliative care approaches from 
a proposed national framework, and specific evidence-based interventions (related 
to communication/decision-making, care models, determinants of place of dying, 
education, and life-sustaining care) identified through systematic reviews con-
ducted by Health Quality Ontario.
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objeCtives: DVT can lead to significant co-morbidity with post-thrombotic syn-
drome, and has the potential to cause life threatening pulmonary emboli. The 
national institute for clinical excellence (NICE) implemented stringent guidelines 
to improve screening for DVT and optimise management (NICE 2012). The Royal 
London Hospital was the designated teaching hospital receiving attending public, 
foreign dignitaries and athletes during the 2012 Olympics. We conducted a pro-
spective audit to assess incidence of DVT in a mobile population during the 2012 
Olympics, and assess adherence to NICE guidelines. Methods: Patients present-
ing with symptoms of DVT over 7 weeks during the 2012 Olympics were seen by a 
senior nurse. A clinical proforma identifying risk factors was employed. D-dimer 
and USS results were obtained from clinical reporting systems. Analysis undertaken 
on excel. Results: 69 patients with a suspected DVT underwent investigations. 
Only six patients had a DVT on Doppler USS. One DVT was deemed unprovoked 
in a young patient with upper limb DVT. In this patient CT abdomen/pelvis was 
not warranted, though tested for antiphospholipid syndrome, serum calcium was 
not measured. In the D-dimer positive scan negative cohort, a repeat USS Doppler 
at 6-8 days was not undertaken in 71% of patients. However, the initial scan was 
undertaken within 24hrs (86%). D-dimer has low sensitivity for DVT diagnosis (14%), 
but high specificity (100%) albeit within limited sample size. Further, utilising risk 
factors (Wells score) alone had a better sensitivity (28%). ConClusions: We note 
a low incidence of DVT in this young mobile population, in comparison to the gen-
eral population. A repeat Doppler USS 6-8days after presentation, when D-dimer 
was positive, is not adhered to; however none performed were positive (9). We are 
uncertain if this approach would add to a reduction in morbidity/mortality (BMJ 
2012). The D-dimer is not a sensitive marker of DVT, and risk stratification through 
identification of risk factors appears more sensitive.
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coMPaRing PuBlic influenza iMMunization PRogRaMMeS in ontaRio 
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COPD and bacterial pneumonia. We used chi-square tests and logistic regressions to 
assess the unadjusted and adjusted relationships between depression and presence 
of ACSH. Results: Among all Medicare beneficiaries, 10% had diagnosed depres-
sion; “any ACSH” was reported in 5% of all elderly 25% of hospitalized elderly. “Any 
ACSH” was higher in Medicare beneficiaries with depression (11.4%) as compared to 
those without depression (4.5%). Among hospitalized elderly, 28% with depression 
and 24% without depression had “any ACSH”. Among all elderly, those with depres-
sion had two times the risk of experiencing “any ACSH” (Adjusted Odds Ratio(AOR): 
2.19; 95% Confidence Interval(CI): 1.97, 2.43) compared to those without depression. 
We observed similar findings for “chronic ACSH” (AOR: 2.44; 95% CI: 2.10, 2.84), “acute 
ACSH” and (AOR:1.98; 95%CI: 1.75, 2.25). ConClusions: Our study results indicated 
that Medicare beneficiaries with chronic physical conditions and depression were at 
risk for ACSHs. Elderly with depression chronic conditions may need to be routinely 
screened for depression. Future research needs to examine whether treating depres-
sion can reduce the risk of ACSH among elderly with depression.
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objeCtives: To assess spirometry testing and chronic obstructive pulmonary dis-
ease (COPD)-related inpatient readmission rates among managed care patients 
in the US. Methods: This retrospective administrative claims database analysis 
included patients with COPD (≥ 1 inpatient or emergency room claim or ≥ 2 outpa-
tient claims with a COPD diagnosis [ICD-9-CM diagnosis codes 491.xx, 492.xx, 494.
xx, or 496.xx]), ≥ 1 month health plan enrollment in 2011 and aged ≥ 40 years. Two 
cohorts were formed: 1) ‘Spirometry’ cohort: Patients with 24 months of enroll-
ment before and 6 months after their initial COPD diagnosis and 2) ‘Readmissions’ 
cohort: Patients with a COPD-related hospitalization (hospitalization with a primary 
diagnosis of COPD) and ≥ 1 month enrollment post-discharge). The proportion of 
patients with evidence of spirometry testing (≥ 1 claim with a CPT-4 procedure code: 
94010, 94060, 95070, 94070, 94150, 94200, 94375, or 94664) within 24 months pre- and 
6 months post-initial COPD diagnosis was assessed in the ‘Spirometry’ cohort. The 
proportion of patients with a COPD-related inpatient readmission within 30 days 
post-discharge (30-day readmission) was assessed in the ‘Readmissions’ cohort. 
Results were reported at the national, regional, and state levels. Results: A total 
of 94,778 patients were included in the ‘Spirometry’ cohort, with 37.6% having evi-
dence of spirometry testing (Northeast: 40.3%; South: 37.4%; Midwest: 37.7%; West: 
31.6%). Spirometry testing rates varied from 24.6% in Wyoming to 61.2% in Rhode 
Island. A total of 49,986 patients were included in the ‘Readmissions’ cohort, with 
7.1% having a 30-day readmission (Northeast: 7.9%; South: 6.3%; Midwest: 7.4%; 
West: 7.1%). Thirty-day readmission rates varied from 2.0% in South Dakota to 20.8% 
in Washington, DC. ConClusions: A large proportion of patients with a COPD 
diagnosis did not have evidence of spirometry testing to confirm COPD diagnosis. 
COPD-related 30-day readmissions may be of concern as well. There is a substantial 
variation in these rates across US states.
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Reconciliation PRogRaM
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objeCtives: Medication-related errors account for many deaths annually, and there 
is increasing evidence that these errors frequently occur upon hospital admission 
and discharge. A pharmacist-conducted pilot program was designed to provide 
medication reconciliation services to high-risk patients shortly after hospital dis-
charge to decrease medication-related errors. The primary objective is to evaluate 
the impact of a post-discharge quality improvement medication reconciliation ser-
vice. Methods: An algorithm was developed to identify patients at high-risk for 
readmission following hospital discharge. High-risk patients were defined as any 
member recently discharged from the hospital who was: a) receiving a high alert 
medication (e.g., warfarin); and/or b) was hospitalized for at least one pre-speci-
fied condition (e.g., Diabetes Mellitus). Within 2-5 days of hospital discharge, the 
Concurrent Review Nurses from a local health plan identified the high risk patients 
using the algorithm and notified the pharmacist. The pharmacist contacted the 
patients via phone to complete a medication reconciliation and clinical review with 
either the patient or their caregiver Results: The program lasted from July 2013 to 
October 2013. In total, 125 patients were identified as high-risk patients, 47 of whom 
completed a clinical consult with the pharmacist. The average age of the patients 
who participated in the service was 66. The use of high-risk meds included warfarin 
(21%), antiplatelets (34%), digoxin (13%), and insulin (28%). In total, 5 patients in this 
group (11%) were re-hospitalized within 30 days. ConClusions: In the future, this 
pilot program should be conducted on a larger scale and include patients who are 
followed for a longer period of time. Anecdotal evidence suggested that the service 
was useful, however a larger number of patients is needed to achieve sufficient 
power to detect a statistical difference.
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objeCtives: Depression is a leading cause of morbidity and disability worldwide. 
The population in developing countries is at greater risk. Inadequate trained men-
tal health staff, and unfortunately, low case detection has been associated with 
increased morbidity among subjects presenting to primary care. In order to com-
